CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823562771
- Phone
- (650) 457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $111,656
- in 2 filings
Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-13 | SCHMIDT ERIC THOMAS Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +83,500 | 83,500 | ||
| 2019-03-13 | Belldegrun Arie Director | Grant or award | +115,333 | 150,333 | ||
| 2019-03-13 | Belldegrun Arie Director | Grant or award · Stock Option (Right to Buy) | +195,133 | 195,133 | ||
| 2019-03-13 | Chang David D President and CEO | Grant or award | +173,000 | 2,168,625 | ||
| 2019-03-13 | Chang David D President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +292,700 | 292,700 | ||
| 2018-10-15 | Belldegrun Arie Director | Purchase | +194,445 | $18.00 | $3.5M | 1,691,781 |
| 2018-10-15 | MESSEMER DEBORAH M. Director | Other acquisition | +6,535 | 6,535 | ||
| 2018-10-15 | WITTE OWEN N. Director | Purchase | +15,000 | $18.00 | $270K | 198,750 |
| 2018-10-15 | WITTE OWEN N. Director | Conversion | +37,432 | 236,182 | ||
| 2018-10-15 | WITTE OWEN N. Director | Conversion · Series A Convertible Preferred Stock | −7,130 | 0 | ||
| 2018-10-15 | Humer Franz B Director | Purchase | +30,000 | $18.00 | $540K | 30,000 |
| 2018-10-15 | Humer Franz B Director | Conversion | +74,870 | 104,870 | ||
| 2018-10-15 | Humer Franz B Director | Conversion · Series A Convertible Preferred Stock | −14,261 | 0 | ||
| 2018-10-15 | Kazam Joshua A Director | Conversion | +18,716 | 1,390,651 | ||
| 2018-10-15 | Kazam Joshua A Director | Conversion · Series A Convertible Preferred Stock | −3,565 | 0 | ||
| 2018-10-15 | Chang David D President and CEO | Purchase | +40,000 | $18.00 | $720K | 1,995,625 |
| 2018-10-15 | Chang David D President and CEO | Conversion | +29,946 | 1,101,838 | ||
| 2018-10-15 | Chang David D President and CEO | Conversion · Series A Convertible Preferred Stock | −5,704 | 0 | ||
| 2018-10-15 | Belldegrun Arie Director | Purchase | +35,000 | $18.00 | $630K | 35,000 |
| 2018-10-15 | Belldegrun Arie Director | Conversion | +142,248 | 3,710,006 |
Page 22 of 23 · 451 trades